Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Pharmaxis Ltd ( (AU:SNT) ) has shared an announcement.
Syntara Limited has announced the quotation of 978,000 ordinary fully paid securities on the Australian Securities Exchange (ASX) under the code SNT. This move follows the exercise of options or conversion of other convertible securities, and it is expected to enhance the company’s market presence and liquidity.
The most recent analyst rating on (AU:SNT) stock is a Buy with a A$0.12 price target. To see the full list of analyst forecasts on Pharmaxis Ltd stock, see the AU:SNT Stock Forecast page.
More about Pharmaxis Ltd
Average Trading Volume: 11,063,710
Technical Sentiment Signal: Sell
Current Market Cap: A$82.87M
For a thorough assessment of SNT stock, go to TipRanks’ Stock Analysis page.